Skip to content
EntityQ415353· pop 14· linked from 100 articles

bremelanotide

Sign in to save

Wikidata facts

Mass
1024.524
Show 3 more facts
chemical formula
C₅₀H₆₈N₁₄O₁₀
isomeric SMILES
CCCC[C@@H](C(=O)N[C@H]1CC(=O)NCCCC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC1=O)CC2=CN=CN2)CC3=CC=CC=C3)CCCN=C(N)N)CC4=CNC5=CC=CC=C54)C(=O)O)NC(=O)C
canonical SMILES
CCCCC(C(=O)NC1CC(=O)NCCCCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CC2=CN=CN2)CC3=CC=CC=C3)CCCN=C(N)N)CC4=CNC5=CC=CC=C54)C(=O)O)NC(=O)C
Sources (1)

via Wikidata · CC0

~12 min read

Article

11 sections
Contents
  • Medical uses
  • Contraindications
  • Side effects
  • Interactions
  • Pharmacology
  • Pharmacodynamics
  • Pharmacokinetics
  • Chemistry
  • History
  • See also
  • References

{{Drugbox | Verifiedfields = verified | Watchedfields = verified | verifiedrevid = 445399889 | image = Bremelanotide structure.svg | image_class = skin-invert-image | width = 250 | alt = | pronounce = | tradename = Vyleesi | Drugs.com = | MedlinePlus = a619054 | licence_CA = | licence_EU = | DailyMedID = Bremelanotide | licence_US = | pregnancy_AU = | pregnancy_AU_comment = | pregnancy_category = | routes_of_administration = Subcutaneous | class = Melanocortin receptor agonist | ATCvet = | ATC_prefix = G02 | ATC_suffix = CX05 | ATC_supplemental = | legal_AU = | legal_AU_comment = | legal_BR = | legal_BR_comment = | legal_CA = | legal_CA_comment = | legal_DE = | legal_DE_comment = | legal_NZ = | legal_NZ_comment = | legal_UK = | legal_UK_comment = | legal_US = Rx-only | legal_US_comment = | legal_UN = | legal_UN_comment = | legal_status =

| bioavailability = : ~100% | protein_bound = 21% | metabolism = Hydrolysis of peptide bonds | metabolites = | onset = | elimination_half-life = 2.7 hours | duration_of_action = | excretion = Urine: 64.8%Feces: 22.8%

Connections

Categories